Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Etanercept biosimilar LBEC-0101 demonstrates equivalence to original

Nov. 24, 2017

Immunoproteasome inhibitor KZR-616 shows promise in phase I study

Nov. 22, 2017

Kaken Pharmaceutical evaluates novel prostanoid EP4 receptor antagonist for rheumatoid arthritis

Nov. 22, 2017

Full U.S. commercial launch for Zilretta

Nov. 21, 2017

Inception 1 discovers novel NADPH oxidase 4 inhibitors

Nov. 16, 2017

Galapagos's GLPG-1972 well tolerated in healthy volunteers

Nov. 16, 2017

Numerate receives grant from NIH to develop EZH2 inhibitor-coated orthopedic implants

Nov. 16, 2017

Boehringer Ingelheim's adalimumab biosimilar, Cyltezo, approved in E.U.

Nov. 15, 2017

Dosing begins in first-in-human phase Ib study of DEN-181

Nov. 15, 2017

Clinical progress reported for Pfizer's IRAK-4 inhibitor PF-06650833

Nov. 15, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...